Consolidated figures · ₹ crore
| ₹ Cr | Jun 2026 |
|---|---|
| Revenue | 122 |
| COGS | 42 |
| Gross profit | 80 |
| 62 | |
| 18 | |
| OPM % | 14.8% |
| Depreciation | 5 |
| Interest | 3 |
| 4 | |
| Profit before tax | 15 |
| Tax | 5 |
| Tax % | 35.1% |
| PAT | 10 |
| PAT margin % | 7.8% |
| EPS (₹) | 3.4 |
| Results filing | Results filing for Jun 2026 |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Bulk drugs/chemicals | 117.39 | 19.05 | 529.63 | 103 | 426.63 |
| Unallocated | 6.81 | -1.89 | 127.69 | 112.5 | 15.19 |
| Property (Refer Note 4) | 1.99 | 0.07 | 8.63 | 38.94 | — |
₹ crore by quarter